Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov ID: NCT04895696

Public ClinicalTrials.gov record NCT04895696. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus

Study identification

NCT ID
NCT04895696
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
268 participants

Conditions and interventions

Interventions

  • Afimetoran Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2021
Primary completion
Jun 17, 2026
Completion
Apr 21, 2029
Last update posted
May 13, 2026

2021 – 2029

United States locations

U.S. sites
36
U.S. states
17
U.S. cities
33
Facility City State ZIP Site status
Local Institution - 0100 Birmingham Alabama 35205
Local Institution - 0123 Huntington Beach California 92648
Local Institution - 0170 La Jolla California 92037
Local Institution - 0159 La Palma California 90623
Local Institution - 0172 San Diego California 92128
Local Institution - 0164 Woodland Hills California 91364
Local Institution - 0121 Clearwater Florida 33765
Local Institution - 0167 Kissimmee Florida 34741
Local Institution - 0122 Orlando Florida 32808
Local Institution - 0173 Ormond Beach Florida 32174
Local Institution - 0154 Plantation Florida 33324
Local Institution - 0137 South Miami Florida 33143
Local Institution - 0155 Tamarac Florida 33321
Local Institution - 0160 Atlanta Georgia 30318
Local Institution - 0205 Suwanee Georgia 30024
Local Institution - 0146 Orland Park Illinois 60467
Local Institution - 0187 Hopkinsville Kentucky 42240
Local Institution - 0171 Baton Rouge Louisiana 70836
Local Institution - 0134 Wheaton Maryland 20902
Local Institution - 0070 Eagan Minnesota 55121
Local Institution - 0124 St Louis Missouri 63110
Local Institution - 0165 St Louis Missouri 63141
Local Institution - 0091 Las Vegas Nevada 89128
Local Institution - 0219 West Long Branch New Jersey 07764
Local Institution - 0140 Manhasset New York 11030
Local Institution - 0132 The Bronx New York 10461
Local Institution - 0203 Charlotte North Carolina 28204
Local Institution - 0103 Charlotte North Carolina 28211
Local Institution - 0151 Columbus Ohio 43203
Local Institution - 0042 Middleburg Heights Ohio 44130
Local Institution - 0152 Allen Texas 75013
Local Institution - 0197 Allen Texas 75013
Local Institution - 0136 Amarillo Texas 79124
Local Institution - 0029 Mesquite Texas 75150
Local Institution - 0163 San Antonio Texas 78215
Local Institution - 0223 Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04895696, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04895696 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →